A new guanidine diuretic, amipramizide: reduction of the kaliuretic effect of ethacrynic acid in man.
D000328:Adult; D001835:Body Weight; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy*; D004976:Ethacrynic Acid / Q000009:adverse effects*; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D011188:Potassium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012964:Sodium / Q000097:blood / Q000652:urine; D014882:Water-Electrolyte Balance
D004232:Diuretics; D006146:Guanidines; D012964:Sodium; D004976:Ethacrynic Acid; D011188:Potassium